• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期蛋白D1降解的调控:在癌症发展中的作用及治疗干预潜力

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.

作者信息

Alao John P

机构信息

Department of Cell and Molecular Biology, Lundberg Laboratory, Gothenburg University, Gothenburg, Sweden.

出版信息

Mol Cancer. 2007 Apr 2;6:24. doi: 10.1186/1476-4598-6-24.

DOI:10.1186/1476-4598-6-24
PMID:17407548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1851974/
Abstract

Cyclin D1 is an important regulator of cell cycle progression and can function as a transcriptionl co-regulator. The overexpression of cyclin D1 has been linked to the development and progression of cancer. Deregulated cyclin D1 degradation appears to be responsible for the increased levels of cyclin D1 in several cancers. Recent findings have identified novel mechanisms involved in the regulation of cyclin D1 stability. A number of therapeutic agents have been shown to induce cyclin D1 degradation. The therapeutic ablation of cyclin D1 may be useful for the prevention and treatment of cancer. In this review, current knowledge on the regulation of cyclin D1 degradation is discussed. Novel insights into cyclin D1 degradation are also discussed in the context of ablative therapy. A number of unresolved questions regarding the regulation of cellular cyclin D1 levels are also addressed.

摘要

细胞周期蛋白D1是细胞周期进程的重要调节因子,可作为转录共调节因子发挥作用。细胞周期蛋白D1的过表达与癌症的发生和发展有关。细胞周期蛋白D1降解失调似乎是几种癌症中细胞周期蛋白D1水平升高的原因。最近的研究发现了参与细胞周期蛋白D1稳定性调节的新机制。已证明多种治疗药物可诱导细胞周期蛋白D1降解。细胞周期蛋白D1的治疗性消除可能对癌症的预防和治疗有用。在这篇综述中,讨论了关于细胞周期蛋白D1降解调节的当前知识。在消融治疗的背景下,也讨论了对细胞周期蛋白D1降解的新见解。还解决了一些关于细胞周期蛋白D1水平调节的未解决问题。

相似文献

1
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.细胞周期蛋白D1降解的调控:在癌症发展中的作用及治疗干预潜力
Mol Cancer. 2007 Apr 2;6:24. doi: 10.1186/1476-4598-6-24.
2
Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.组蛋白去乙酰化酶抑制剂曲古抑菌素A可诱导MCF-7乳腺癌细胞中泛素依赖性细胞周期蛋白D1降解。
Mol Cancer. 2006 Feb 20;5:8. doi: 10.1186/1476-4598-5-8.
3
GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.糖原合成酶激酶-3β调节细胞周期蛋白D1的表达:化疗的新靶点。
Cell Signal. 2008 Apr;20(4):581-9. doi: 10.1016/j.cellsig.2007.10.018. Epub 2007 Oct 23.
4
BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.BRCA1-IRIS通过下调JNK磷酸酶DUSP3/VHR来激活乳腺癌细胞中细胞周期蛋白D1的表达。
Int J Cancer. 2007 Jul 1;121(1):39-46. doi: 10.1002/ijc.22597.
5
Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.在卵巢癌细胞中,尽管细胞周期蛋白E2持续表达,但细胞周期蛋白D1的降解足以诱导G1期细胞周期停滞。
Cancer Res. 2009 Aug 15;69(16):6565-72. doi: 10.1158/0008-5472.CAN-09-0913. Epub 2009 Jul 28.
6
Suppression of cancer cell growth by promoting cyclin D1 degradation.通过促进细胞周期蛋白 D1 降解来抑制癌细胞生长。
Mol Cell. 2009 Nov 13;36(3):469-76. doi: 10.1016/j.molcel.2009.10.018.
7
A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.FBXW8 和 MAPK 在细胞周期蛋白 D1 降解和癌细胞增殖中的关键作用。
PLoS One. 2006 Dec 27;1(1):e128. doi: 10.1371/journal.pone.0000128.
8
Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.乳腺癌细胞中细胞周期蛋白D1的诱导性过表达可逆转抗雌激素的生长抑制作用。
Clin Cancer Res. 1997 Jun;3(6):849-54.
9
PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.PSAT1 调控细胞周期蛋白 D1 的降解并维持非小细胞肺癌细胞的增殖。
Int J Cancer. 2015 Feb 15;136(4):E39-50. doi: 10.1002/ijc.29150. Epub 2014 Sep 2.
10
Nuclear cyclin D1: an oncogenic driver in human cancer.细胞核周期蛋白D1:人类癌症中的致癌驱动因子。
J Cell Physiol. 2009 Aug;220(2):292-6. doi: 10.1002/jcp.21791.

引用本文的文献

1
Metformin as a promising therapeutic agent for papillary thyroid cancer: Mechanisms of antitumor and pro-apoptotic activity.二甲双胍作为甲状腺乳头状癌一种有前景的治疗药物:抗肿瘤及促凋亡活性机制
Transl Oncol. 2025 Jul 29;60:102483. doi: 10.1016/j.tranon.2025.102483.
2
Probiotics as Anti-Tumor Agents: Insights from Female Tumor Cell Culture Studies.益生菌作为抗肿瘤剂:来自女性肿瘤细胞培养研究的见解
Biomolecules. 2025 May 2;15(5):657. doi: 10.3390/biom15050657.
3
Mechanism of D-type cyclin recognition by the AMBRA1 E3 ligase receptor.AMBRA1 E3 连接酶受体识别 D 型细胞周期蛋白的机制。

本文引用的文献

1
Uncovering residues that regulate cyclin D1 proteasomal degradation.揭示调控细胞周期蛋白D1蛋白酶体降解的残基。
Oncogene. 2007 Aug 2;26(35):5098-106. doi: 10.1038/sj.onc.1210309. Epub 2007 Feb 19.
2
p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells.p38介导的细胞周期蛋白D1/细胞周期蛋白依赖性激酶4失活刺激RelA在结直肠癌细胞中的核仁易位并诱导凋亡。
Cancer Res. 2007 Feb 15;67(4):1660-9. doi: 10.1158/0008-5472.CAN-06-1038.
3
Uncovering novel targets for cancer chemoprevention.
Sci Adv. 2025 May 23;11(21):eadu8708. doi: 10.1126/sciadv.adu8708.
4
Integrated Network Analysis Decipher ZNF384-Related miR-20b-5p and miR-424-5p in Colon Adenocarcinoma.整合网络分析解析结肠癌中与ZNF384相关的miR-20b-5p和miR-424-5p
Cancer Rep (Hoboken). 2025 May;8(5):e70233. doi: 10.1002/cnr2.70233.
5
Niclosamide: CRL4 mediated degradation of cyclin D1 following mitochondrial membrane depolarization.氯硝柳胺:线粒体膜去极化后CRL4介导的细胞周期蛋白D1降解。
RSC Med Chem. 2025 May 6. doi: 10.1039/d5md00054h.
6
Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity.白藜芦醇对癌症中PI3K/Akt信号通路的调节:分子机制与治疗机遇
Discov Oncol. 2025 May 5;16(1):669. doi: 10.1007/s12672-025-02471-w.
7
Synergistic effects of doxorubicin and coumarin on colorectal cancer cell proliferation and EMT modulation: and study.阿霉素与香豆素对结肠癌细胞增殖及上皮-间质转化调节的协同作用:一项 和 研究。 (注:原文中“and study”前似乎缺失了一些内容)
Ann Med Surg (Lond). 2025 Jan 30;87(3):1271-1281. doi: 10.1097/MS9.0000000000002922. eCollection 2025 Mar.
8
The molecular landscape of AL amyloidosis.AL淀粉样变性的分子图谱。
Br J Haematol. 2025 May;206(5):1297-1311. doi: 10.1111/bjh.20070. Epub 2025 Apr 11.
9
c-Jun promotes neuroblastoma cell differentiation by inhibiting APC formation via CDC16 and reduces neuroblastoma malignancy.c-Jun通过CDC16抑制APC形成来促进神经母细胞瘤细胞分化,并降低神经母细胞瘤的恶性程度。
Biol Direct. 2025 Mar 27;20(1):37. doi: 10.1186/s13062-025-00630-1.
10
Obese Adipose Tissue Extracellular Vesicles Activate Mitochondrial Fatty Acid β-oxidation to Drive Colonic Stemness.肥胖脂肪组织细胞外囊泡激活线粒体脂肪酸β-氧化以驱动结肠干细胞特性。
Cell Mol Gastroenterol Hepatol. 2025;19(7):101504. doi: 10.1016/j.jcmgh.2025.101504. Epub 2025 Mar 22.
发现癌症化学预防的新靶点。
Recent Results Cancer Res. 2007;174:235-43. doi: 10.1007/978-3-540-37696-5_21.
4
A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.FBXW8 和 MAPK 在细胞周期蛋白 D1 降解和癌细胞增殖中的关键作用。
PLoS One. 2006 Dec 27;1(1):e128. doi: 10.1371/journal.pone.0000128.
5
Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell.细胞周期中细胞周期蛋白D1水平的变化决定了细胞的增殖命运。
Cell Div. 2006 Dec 18;1:32. doi: 10.1186/1747-1028-1-32.
6
F-box proteins: more than baits for the SCF?F-box蛋白:仅仅是SCF的诱饵吗?
Cell Div. 2006 Dec 13;1:30. doi: 10.1186/1747-1028-1-30.
7
Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.SCF(FBX4-αB晶状体蛋白)复合物介导的细胞周期蛋白D1的磷酸化依赖性泛素化
Mol Cell. 2006 Nov 3;24(3):355-66. doi: 10.1016/j.molcel.2006.09.007.
8
Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.GSK-3β和DYRK1B参与分化诱导因子-3诱导的HeLa细胞中细胞周期蛋白D1的磷酸化过程。
J Biol Chem. 2006 Dec 15;281(50):38489-97. doi: 10.1074/jbc.M605205200. Epub 2006 Oct 17.
9
mTOR, translation initiation and cancer.哺乳动物雷帕霉素靶蛋白、翻译起始与癌症
Oncogene. 2006 Oct 16;25(48):6416-22. doi: 10.1038/sj.onc.1209888.
10
Multiple molecular targets in cancer chemoprevention by curcumin.姜黄素在癌症化学预防中的多个分子靶点。
AAPS J. 2006 Jul 7;8(3):E443-9. doi: 10.1208/aapsj080352.